Low-dose amitriptyline in irritable bowel syndrome: ready for primary care?

Lancet. 2023 Nov 11;402(10414):1727-1728. doi: 10.1016/S0140-6736(23)01725-7. Epub 2023 Oct 16.

Authors

Niek de Wit¹, Daniel Keszthelyi²

Affiliations

¹ Julius Center for Health Sciences and Primary Care, UMC Utrecht, 3584 CG Utrecht, Netherlands. Electronic address: n.j.dewit@umcutrecht.nl.
² Department of Gastroenterology, Maastricht UMC, Maastricht, Netherlands.

PMID: 37858321
DOI: 10.1016/S0140-6736(23)01725-7

No abstract available

Publication types

Comment

MeSH terms

Amitriptyline / therapeutic use
Analgesics, Non-Narcotic*
Diarrhea
Humans
Irritable Bowel Syndrome* / drug therapy
Primary Health Care

Substances

Amitriptyline
Analgesics, Non-Narcotic